Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma Of Esophagus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00667420
What this trial is testing

Perioperative Panitumumab and Epirubicin, Oxaliplatin and Xeloda (EOX) in Patients With Gastroesophageal Adenocarcinoma

Who this might be right for
Esophageal AdenocarcinomaGastric Adenocarcinoma
Massachusetts General Hospital 17
Early research (Phase 1)Ended earlyNCT02283359
What this trial is testing

Selinexor in Combination With Irinotecan in Adenocarcinoma of Stomach and Distal Esophagus

Who this might be right for
Esophageal CancerGastric Cancer
H. Lee Moffitt Cancer Center and Research Institute 3
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07164690
What this trial is testing

Low-Dose Radiotherapy in Patients With Advanced Esophageal Squamous Cell Carcinoma Resistant to First-Line Chemotherapy Combined With Immunotherapy

Who this might be right for
Esophageal AdenocarcinomaRadiotherapy
Fudan University 32
Testing effectiveness (Phase 2)Looking for participantsNCT07223424
What this trial is testing

Patient Preference for Subcutaneous vs. Intravenous Immune Therapy

Who this might be right for
Renal Cell CarcinomaNon Small Cell Lung CancerMelanoma+9 more
Diwakar Davar 880
Testing effectiveness (Phase 2)Study completedNCT00544362
What this trial is testing

Fluorouracil, Cisplatin, Cetuximab, and Radiation Therapy in Treating Patients With Esophageal Cancer That Can Be Removed by Surgery

Who this might be right for
Esophageal Cancer
Federation Francophone de Cancerologie Digestive 33
Not applicableLooking for participantsNCT05530343
What this trial is testing

Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance

Who this might be right for
Barrett EsophagusBarretts Esophagus With DysplasiaEsophageal Adenocarcinoma
University of Colorado, Denver 2,298
Testing effectiveness (Phase 2)Looking for participantsNCT05177133
What this trial is testing

Anti-PD-1 and CapOx for the First-line Treatment of dMMR Esophagogastric Cancer (AuspiCiOus)

Who this might be right for
Gastric AdenocarcinomaEsophageal Adenocarcinoma
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 25
Early research (Phase 1)Active Not RecruitingNCT04391049
What this trial is testing

Testing the Addition of the Anti-cancer Viral Therapy Telomelysin™ to Chemoradiation for Patients With Advanced Esophageal Cancer and Are Not Candidates for Surgery

Who this might be right for
Advanced Esophageal AdenocarcinomaAdvanced Gastroesophageal Junction AdenocarcinomaClinical Stage II Esophageal Adenocarcinoma AJCC v8+30 more
NRG Oncology 16
Early research (Phase 1)Looking for participantsNCT04389632
What this trial is testing

Sigvotatug Vedotin in Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small Cell LungSquamous Cell Carcinoma of Head and NeckHER2 Negative Breast Neoplasms+9 more
Seagen, a wholly owned subsidiary of Pfizer 1,006
Early research (Phase 1)Study completedNCT05411133
What this trial is testing

Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients

Who this might be right for
Gastrointestinal CancerCholangiocarcinomaLiver Cancer+6 more
Arbele Pty Ltd 33
Early research (Phase 1)Looking for participantsNCT07334119
What this trial is testing

Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid Tumors

Who this might be right for
HER2-Expressing Solid Tumors
Myeloid Therapeutics 60
Testing effectiveness (Phase 2)Ended earlyNCT00064259
What this trial is testing

A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction Cancer

Who this might be right for
Adenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the Stomach+11 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Study completedNCT00033657
What this trial is testing

Radiation Therapy and Chemotherapy Before and After Surgery in Treating Patients With Esophageal Cancer

Who this might be right for
Esophageal CancerGastric Cancer
Eastern Cooperative Oncology Group 97
Testing effectiveness (Phase 2)UnknownNCT00057395
What this trial is testing

A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies

Who this might be right for
Esophageal NeoplasmsHepatocellular CarcinomaColorectal Neoplasms+3 more
Aronex Pharmaceuticals 40
Not applicableEnrolling By InvitationNCT00587314
What this trial is testing

The Effect of Ablation Therapy on Barrett's Esophagus

Who this might be right for
Barrett's EsophagusEarly Esophageal Adenocarcinoma
Mayo Clinic 600
Not applicableStudy completedNCT02415101
What this trial is testing

Timing of Resective Surgery After Neoadjuvant Chemoradiotherapy in Esophageal Cancer

Who this might be right for
Cancer of the Esophagus
Karolinska University Hospital 202
Not applicableStudy completedNCT00586872
What this trial is testing

Endoscopic Mucosal Resection (EMR) in Barrett's Esophagus

Who this might be right for
Barrett's EsophagusEarly Esophageal Adenocarcinoma
Mayo Clinic 1,000
Testing effectiveness (Phase 2)Ended earlyNCT02530437
What this trial is testing

Taladegib, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Localized Esophageal or Gastroesophageal Junction Cancer

Who this might be right for
Gastroesophageal Junction AdenocarcinomaStage IB Esophageal Adenocarcinoma AJCC v7Stage II Esophageal Adenocarcinoma AJCC v7+4 more
M.D. Anderson Cancer Center 7
Testing effectiveness (Phase 2)Study completedNCT03339843
What this trial is testing

Multiorgan Metabolic Imaging Response Assessment of Abemaciclib

Who this might be right for
Esophageal AdenocarcinomaEsophagus SCCCholangiocarcinoma+2 more
Jules Bordet Institute 85
Testing effectiveness (Phase 2)Active Not RecruitingNCT04028167
What this trial is testing

Induction FLOT With CROSS CRT for Esophageal Cancer

Who this might be right for
Adenocarcinoma EsophagusAdenocarcinoma of the Gastroesophageal Junction
University of Colorado, Denver 40
Next Page